Xeljanz XR 11 mg (Tofacitinib (Tofacitinib Citrate) TABLET (EXTENDED-RELEASE)) 11 MG

Xeljanz XR 11 mg is an extended-release tablet containing tofacitinib citrate, used for managing certain inflammatory conditions. This medication is designed for oral administration and is manufactured by Pfizer Canada ULC.

Strength

11 MG

Pack Size

14/30

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xeljanz XR 11 mg is primarily used for the treatment of moderate to severe rheumatoid arthritis in adults who have not responded well to other medications. It works by reducing inflammation and immune system activity. This drug may also be prescribed for other inflammatory conditions as determined by a healthcare provider.

Side Effects

Common effects of Xeljanz XR 11 mg may include headache, diarrhea, and upper respiratory tract infections. Some users might experience nausea or changes in blood cell counts. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Xeljanz XR 11 mg should be handled with care, especially for individuals with a history of infections, blood clots, or liver problems. Regular blood tests may be recommended to monitor for potential side effects. Always follow the advice of a healthcare provider regarding the use of this medication.

Avoid Interactions

Xeljanz XR 11 mg may interact with other medications, including those that suppress the immune system or affect liver enzymes. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be consumed with caution while using this medication.

References

Frequently Asked Questions

Xeljanz XR 11 mg is used to manage moderate to severe rheumatoid arthritis in adults who have not responded well to other treatments.

Xeljanz XR 11 mg is an extended-release tablet taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include headache, diarrhea, and upper respiratory tract infections. Always consult a healthcare provider for personalized advice.

Xeljanz XR 11 mg may interact with other medications, so it's important to discuss all your current medications with your healthcare provider.

Xeljanz XR 11 mg may not be suitable for individuals with certain medical conditions, such as severe infections or blood clots. Always consult a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.